Logotype for Ramsay Générale de Santé S.A

Ramsay Générale de Santé (GDS) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Ramsay Générale de Santé S.A

H1 2025 earnings summary

19 Aug, 2026

Executive summary

  • Revenue rose 5.8% year-over-year to €2,507.2 million for the half-year ended December 31, 2024, driven by activity growth and acquisitions, notably the Cosem primary care centers in France.

  • EBITDA remained stable at €284.6 million, with margin declining to 11.4% from 12.0% due to inflation, lower subsidies, and government tariff constraints.

  • Operating income fell 15.5% to €66.1 million, reflecting cost inflation and less favorable government support.

  • Net result attributable to the group was a loss of €43.1 million, with EPS at -€0.39, compared to -€0.16 a year earlier.

  • Patient satisfaction reached a record NPS of 73% in France, and 95% of French facilities achieved top quality certification.

Financial highlights

  • Revenue in France grew 7.2%, supported by the acquisition of 12 Cosem primary care centers and tariff increases.

  • Nordic countries saw 2.7% reported revenue growth, mainly from Swedish hospital activity and Norwegian tariff hikes.

  • Operating margin in France was pressured by inflation, wage increases, and reduced government support.

  • Net financial debt stood at €3,715.6 million at December 31, 2024, up from €3,610.9 million at June 2024, but down from €3,869.9 million a year earlier.

  • Net cash flow from operations increased 13.9% to €169.9 million.

Outlook and guidance

  • The French government’s activity-based support scheme was extended through December 2025, with €20.2 million recognized in H1 2024.

  • Management expects continued operational challenges from inflation and labor competition, but ongoing efficiency plans in the Nordics and new contracts (e.g., St Göran hospital) support future performance.

  • Ongoing negotiations with European governments, especially France, to secure fairer private sector funding and tariff adjustments.

  • Strategic plan "Yes We Care 2025" supported by recent long-term debt refinancing and repricing, providing financial stability for future growth.

  • Focus on expanding digital capabilities, outpatient, and primary care activities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more